Home
The Department of Biomedicine

News archive for The Department of Biomedicine

Thomas Arnesen is one of five Norwegian researchers who will receive a prestigious consolidator grant from the European Research Council in 2017.
Bortezomib as chemosensitizer for glioblastoma patients with unmethylated MGMT promoter: Phase IB/II clinical trial and mechanisms of therapeutic efficacy
Gry Sandvik Haaland defends her dissertation “Investigations of the cancer therapeutic and protective effects of warfarin mediated inhibition of the receptor tyrosine kinase AXL”